HONG KONG, Feb. 11 /PRNewswire-Asia/ -- Golden Meditech Company Limited ("Golden Meditech," or "the Group"; Stock Code: 801), China's leading integrated high-tech healthcare business, is pleased to announce today that the Board of Directors ("the Board") has proposed to change the Company's name into "Golden Meditech Holdings Limited", subject to the shareholders' approval at the forthcoming EGM (Extraordinary General Meeting) and confirmation from the Registrar of Companies in the Cayman Islands. (Note 1)
Mr. KAM Yuen, Chairman and CEO of the Group, said, "The proposed new name will better reflect the Group's diversified healthcare operations built around its core competences, following the recent successful listings of its affiliates, China Cord Blood Corporation (NYSE ticker symbol: CO), the first and largest cord blood bank operator in China and FunTalk China Holding Limited (NASDAQ ticker symbol: FTLK) in the United States."
In addition to the two affiliates aforementioned, the Group's other core businesses also includes awholly-owned subsidiary Beijing Jingjing Medical Equipment Co., Ltd., renowned as China's first and largest manufacturer of autologous blood recovery device, and a hospital management arm is the first foreign-owned entity in China to offer nationwide hospital management and consultancy services.
Mr. Kam further commented, "Across the integrated portfolio of healthcare businesses that we currently operate, we enjoy dominant positions in the various market segments. We believe the new name will better reflect our corporate vision as underpinned by the Group's strategic developments, effectively highlighting the diversity and depth of the Group's businesses from investors' point of view, and is in line with the interests of both the Company and our Shareholders. Our expertise and in-depth knowledge in China market has rendered us in an excellent position to capture the immense opportunities arising from China's rapidly expanding and thriving medical and healthcare industries and beyond."
Note 1: A circular containing details of the proposed Change of Company
Name, together with a notice of the EGM and the related proxy
form, will be dispatched to the Shareholders as soon as
practicable.
About the Company:
Golden Meditech Company Limited is China's leading healthcare group and the first hi-tech medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEX). Thanks to its strengths in innovation and market expertise, as well as its ability in capturing emerging market opportunities, Golden Meditech is a first-mover in China in medical devices, cord blood banking services and innovative natural herbal medicines segments and have established dominant positions in these respective areas over the years. Going forward, the Company will continue its pursuit in becoming China's leading integrated medical group through organic growth, acquisitions and strategic investments.
For inquiry, please kindly contact:
The Investor Relations Division
Golden Meditech Company Limited
Tel: +852-3605-8138
Fax: +852-3605-8181
Email: ir@goldenmeditech.com
Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong.
